News

Novo Nordisk: Examining Tariff And Pricing Risks
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...
Lawsuit alleges Maryland man with diabetes became blind after taking Ozempic
A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...
Say goodbye to cheap versions of Ozempic and Wegovy
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
US Man Becomes Blind After Taking Ozempic Due to a Rare Eye Condition
An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.
Moderna faces suspension over Covid jab breaches
If found to be lacking adequate compliance systems, Moderna could ultimately be suspended or expelled from the Association of ...
Health and Me on MSN20h
US Man Became Blind After Consuming Ozempic: Do Weight Loss Drugs Cause Blindness?
Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...
pharmaphorum23h
Novo Nordisk will file semaglutide for MASH next year
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
pharmaphorum23h
FDA fast-tracks GSK’s chronic hep B therapy bepirovirsen
Other drugs in development for CHB include Dicerna (now part of Novo Nordisk) and Roche’s siRNA candidate xalnesiran, which reported phase 2 data at the AASLD conference last year, and Arrowhead ...